» Authors » Masami Shinohara

Masami Shinohara

Explore the profile of Masami Shinohara including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 35
Citations 480
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Oki C, Uno K, Sasase T, Tsutsui T, Sekiguchi K, Yamaguchi A, et al.
J Vet Med Sci . 2024 Dec; 87(2):138-146. PMID: 39662940
Many genetic and environmental factors are involved in the development and progression of diabetic kidney disease (DKD), and its pathology shows various characteristics. Animal models of DKD play an important...
2.
Tanaka Y, Takagi R, Mitou S, Shimmura M, Hasegawa T, Amarume J, et al.
Biol Pharm Bull . 2024 Mar; 47(3):713-722. PMID: 38432946
Diabetic retinopathy (DR) can cause visual impairment and blindness, and the increasing global prevalence of diabetes underscores the need for effective therapies to prevent and treat DR. Therefore, this study...
3.
Yamamoto T, Kase S, Shinkai A, Murata M, Kikuchi K, Wu D, et al.
Invest Ophthalmol Vis Sci . 2023 Jul; 64(10):20. PMID: 37459063
Purpose: Chronic inflammation plays a pivotal role in the pathology of proliferative diabetic retinopathy (PDR), in which biological alterations of retinal glial cells are one of the key elements. The...
4.
Hasegawa T, Takagi R, Tanaka Y, Ohta T, Shinohara M, Kageyama Y, et al.
Biomed Hub . 2022 Oct; 7(3):106-114. PMID: 36262406
Purpose: The aim of this study was to investigate the effects of different anesthetic agents on electroretinograms (ERGs) in Spontaneously Diabetic Torii fatty rats (SDT fatty rats). Methods: The ERG...
5.
Shinozaki Y, Katayama Y, Yamaguchi F, Suzuki T, Watanabe K, Uno K, et al.
Clin Exp Pharmacol Physiol . 2022 Jan; 49(4):492-500. PMID: 35066915
For the evaluation of novel therapeutic agents for diabetic kidney disease (DKD), it is desirable to examine their efficacy in animal models by using the glomerular filtration rate (GFR) as...
6.
Teoh S, Miyajima K, Shinozaki Y, Shinohara M, Ohata K, Briand F, et al.
J Toxicol Sci . 2021 Dec; 46(12):589-599. PMID: 34853244
Type 2 diabetes mellitus represents an international health concern with its growing number of patients worldwide. At the same time, excessive salt consumption is also seen as a major cause...
7.
Kikuchi K, Murata M, Noda K, Kase S, Tagawa Y, Kageyama Y, et al.
J Diabetes Res . 2020 Aug; 2020:3058547. PMID: 32832559
Spontaneously Diabetic Torii (SDT) fatty rat is a novel animal model of type 2 diabetes with obesity. SDT fatty rats develop hyperglycemia, dyslipidemia, and other diabetic complications including ocular disorders;...
8.
Katsuhiro M, Teoh S, Yamashiro H, Shinohara M, Fatchiyah F, Ohta T, et al.
Med Arch . 2018 Feb; 72(1):4-8. PMID: 29416209
Introduction: Impaired diabetic wound healing is an important issue in diabetic complications. The present study aims to evaluate the protective effect on glycemic control against impaired diabetic wound healing using...
9.
Murai Y, Ohta T, Tadaki H, Miyajima K, Shinohara M, Fatchiyah F, et al.
Med Arch . 2018 Feb; 71(6):380-384. PMID: 29416195
Introduction: The number of diabetic patients has recently been increasing worldwide, and numerous anti-diabetic drugs have been developed to induce good glycemic control. In particular, metformin, which exhibits glucose-lowering effects...
10.
Watanabe K, Fujii H, Goto S, Nakai K, Kono K, Watanabe S, et al.
J Atheroscler Thromb . 2017 Jul; 25(2):170-177. PMID: 28674323
Aim: Chronic kidney disease-mineral bone disorder (CKD-MBD) is associated with all-cause and cardiovascular morbidity and mortality in patients with CKD. Thus, elucidating its pathophysiological mechanisms is essential for improving the...